Skip to content
Search

Latest Stories

Pharmacy staff say reporting errors to improve pharmacy practice and help others learn

Last year, 95 per cent of the pharmacy staff have reported errors to improve pharmacy practice and 80 per cent to help others learn from mistakes, a recent study has found.

The survey conducted by the Community Pharmacy Patient Safety Group on patient safety culture in Autumn 2021 sought to understand patient safety practice from the perspective of frontline pharmacy teams.


According to the anonymous survey, the vast majority (91.4%) of respondents said the reporting procedure was “clear” or “very clear” and a similar proportion (91.6%) said they felt “fairly confident” or “completely confident” following reporting procedures correctly.

The study found that almost two thirds (65%) of respondents were aware of the change to the law, introduced in 2018, which provides a legal defence from criminal prosecution in the event of an inadvertent dispensing error. Of those who are aware of the change to the law, almost a third (29%) said they were more likely to report errors because of it.

Many respondents (59%) requested simpler reporting tools and a third (33%) indicated that training to support reporting would be beneficial. Over half of respondents said that they were either unfamiliar with the terminology “Just Culture” or didn’t know if their organisation followed the principles of it.

Victoria Steele, Chair of the Community Pharmacy Patient Safety Group said: “Community pharmacies deliver incredibly safe care. It will never be possible to eliminate all patient safety incidents in healthcare settings, including pharmacies, but reporting errors is essential if teams are to understand, investigate, learn from and ultimately prevent future incidents.

“We are really pleased to see high levels of confidence in reporting procedures and that teams are motivated to report errors in order to improve practice and share learnings. We note with interest that changes to the law have encouraged colleagues to report errors, however there is work to do to ensure all colleagues are aware of these changes.”

Steele added: “Whilst the results are promising, respondents also highlighted particular areas to support the reporting process including simpler reporting tools and increased training. We encourage contractors and policy makers to take this on board.

“In recent years, many within the pharmacy sector have also raised concerns about growing pressures on the community pharmacy workforce and its potential impact on patient safety. To enable colleagues to learn from errors, it is vital that pharmacy team members feel able to share when things go wrong, and businesses should instill a culture of openness and transparency to support this.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less